Cargando…
Lipohypertrophy contributing to severe diabetic ketoacidosis in type 1 diabetes: An increasing problem in the context of the COVID‐19 pandemic?
A 57‐year‐old man with type 1 diabetes was admitted with diabetic ketoacidosis during the COVID‐19 pandemic. On examination, there was evidence of severe lipohypertrophy on his abdomen. Repeated injection of subcutaneous insulin into areas of lipohypertrophy was thought to have contributed to the de...
Autores principales: | Smith, Emilia Imogen, Ciutac, Andra, Smith, Jamie C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9675868/ https://www.ncbi.nlm.nih.gov/pubmed/36415718 http://dx.doi.org/10.1002/ccr3.6517 |
Ejemplares similares
-
Extent of lipohypertrophy in diabetic patients—Sometimes much more than meets the eye
por: Harsch, Igor Alexander
Publicado: (2019) -
Hypertonic saline versus fluid restriction: The pitfalls in managing acute hyponatremia in a patient with long‐standing spinal cord injury
por: Koutroukas, Vaios, et al.
Publicado: (2022) -
Lipohypertrophy in Elderly Insulin-Treated Patients With Type 2 Diabetes
por: Gentile, Sandro, et al.
Publicado: (2020) -
Tubelight Adrenals in Diabetic Ketoacidosis
por: Yadav, Prakrati, et al.
Publicado: (2020) -
Impact of Insulin Injection and Infusion Routines on Lipohypertrophy and Glycemic Control in Children and Adults with Diabetes
por: Deeb, Asma, et al.
Publicado: (2019)